Skip to main content

Hims & Hers Health, Inc.

corporate_fare Company Profile

Hims & Hers Health, Inc.

HIMS·NYSE·Industrial Applications And Services·CIK 0001773751

Hims & Hers Health, Inc., launched in 2017, operates a consumer-focused platform that helps customers meet their health and wellness needs. The company provides a digital platform that includes access to a network of qualified healthcare providers, an electronic medical record system, digital prescriptions, cloud pharmacy fulfillment, and personalization features. This platform enables access to treatments for various chronic conditions, such as sexual health, hair loss, hormone health, weight loss, dermatology, and mental health, along with services like comprehensive laboratory testing. Hims & Hers connects patients with licensed healthcare professionals who can prescribe medications, including through personalized treatment plans, with prescriptions fulfilled online by licensed pharmacies. Additionally, the company offers a selection of non-prescription health and wellness products. Through its mobile applications, consumers can access educational programs, wellness content, community support, and other services. Since its founding, Hims & Hers has facilitated over fifty million telehealth consultations, providing access to care in the United States, Canada, the United Kingdom, and the European Union (specifically in Germany, the Republic of Ireland, France, and Spain). The company's strategy focuses on its brand, products and services, technology, and clinical excellence.

Hims & Hers Health, Inc. (NYSE:HIMS) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors HIMS SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Hims & Hers Posts $753M in Q2 Revenue, Debuts Full-Year Outlook at $3.1B–$3.3B
  • Hims & Hers Issues First FY Revenue Outlook at $3.1B-$3.3B
  • FTC and States Sue Hims & Hers Over Alleged Sharing of Sensitive Health Data
  • FDA Panel Backs Compounding of Peptide BPC-157, Hims & Hers Shares Jump 8%
  • Chief Accounting Officer Irene Becklund to Depart Hims & Hers After Seven Years

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$2.35B
Net Income
$128.37M
Diluted EPS
$0.51
Op. Cash Flow
$300.01M
Free Cash Flow
$57.41M
Gross Profit
$1.73B
Operating Income
$105.61M
Cash & Equivalents
$228.62M
Total Debt
$972.58M
Debt / Equity
1.80×
Net Margin
5.5%
Shares Outstanding
224.96M sh
Source: 10-K · filed 2026-02-23 · accession 0001773751-26-000022

Dilution Risk

Low risk

Filing-implied dilution signals for HIMS, detected from its recent SEC filings · based on capital-structure filings through 2026-05-21.

Convertible Notes Issued · Favorable Conversion Terms

⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with H →
$27.39
52-week range · as of 2026-08-10 $13.74 – $65.3
Market cap
$6.39B
Volume
7.9M (0.6× avg)
3-mo avg 13.8M
Live data · 2026-08-19 06:18 UTC · Market overnight

show_chartPrice Chart

Loading chart...

feed HIMS - Latest Insights

HIMS
Aug 10, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $31.31
Real-time Price: $27.39 info
Change: -$3.92 (-13%) info
Market Cap: $6.39B info
HIMS
Aug 10, 2026, 4:05 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $29.49
Real-time Price: $27.39 info
Change: -$2.10 (-7%) info
Market Cap: $6.39B info
HIMS
Jul 29, 2026, 1:08 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $26.18
Real-time Price: $27.39 info
Change: +$1.21 (+5%) info
Market Cap: $6.39B info
HIMS
Jul 23, 2026, 2:37 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $33.48
Real-time Price: $27.39 info
Change: -$6.09 (-18%) info
Market Cap: $6.39B info
HIMS
Jul 17, 2026, 4:17 PM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $32.62
Real-time Price: $27.39 info
Change: -$5.23 (-16%) info
Market Cap: $6.39B info
HIMS
Jul 01, 2026, 5:02 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $37.45
Real-time Price: $27.39 info
Change: -$10.06 (-27%) info
Market Cap: $6.39B info
HIMS
Jun 26, 2026, 3:13 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $32.47
Real-time Price: $27.39 info
Change: -$5.08 (-16%) info
Market Cap: $6.39B info
HIMS
Jun 02, 2026, 6:02 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $27.99
Real-time Price: $27.39 info
Change: -$0.600 (-2%) info
Market Cap: $6.39B info
HIMS
Jun 02, 2026, 5:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $27.95
Real-time Price: $27.39 info
Change: -$0.555 (-2%) info
Market Cap: $6.39B info
HIMS
May 26, 2026, 4:48 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $23.79
Real-time Price: $27.39 info
Change: +$3.60 (+15%) info
Market Cap: $6.39B info
HIMS
May 21, 2026, 5:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $24.09
Real-time Price: $27.39 info
Change: +$3.30 (+14%) info
Market Cap: $6.39B info
HIMS
May 19, 2026, 8:17 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $22.16
Real-time Price: $27.39 info
Change: +$5.23 (+24%) info
Market Cap: $6.39B info
HIMS
May 19, 2026, 12:08 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $22.35
Real-time Price: $27.39 info
Change: +$5.04 (+23%) info
Market Cap: $6.39B info
HIMS
May 18, 2026, 7:17 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $23.49
Real-time Price: $27.39 info
Change: +$3.90 (+17%) info
Market Cap: $6.39B info
HIMS
May 12, 2026, 7:28 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $24.62
Real-time Price: $27.39 info
Change: +$2.77 (+11%) info
Market Cap: $6.39B info
HIMS
May 11, 2026, 4:15 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $26.00
Real-time Price: $27.39 info
Change: +$1.39 (+5%) info
Market Cap: $6.39B info
HIMS
May 11, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $26.30
Real-time Price: $27.39 info
Change: +$1.09 (+4%) info
Market Cap: $6.39B info
HIMS
May 11, 2026, 4:06 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $28.06
Real-time Price: $27.39 info
Change: -$0.670 (-2%) info
Market Cap: $6.39B info
HIMS
Apr 28, 2026, 8:23 AM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $28.53
Real-time Price: $27.39 info
Change: -$1.14 (-4%) info
Market Cap: $6.39B info
HIMS
Apr 22, 2026, 11:22 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $28.76
Real-time Price: $27.39 info
Change: -$1.37 (-5%) info
Market Cap: $6.39B info